Friday, October 14, 2016
12:30 – 2pm
Waterhouse Room, Gordon Hall 106
25 Shattuck Street
Boston, MA 02115
Follow @HMSbioethics on Twitter and join the conversation using #policyethx
Description:
The Trans-Pacific Partnership (TPP) Agreement is intended to facilitate trade among 12 Asia-Pacific countries including the US, but its progress has been obstructed in part by ongoing controversy over provisions regarding intellectual property protections for pharmaceutical products. Some argue that if signed, the TPP will impact the availability or cost of essential medicines in low-income settings worldwide by requiring all countries to provide high levels of IP protections mirroring current US standards.
Join us as we discuss the implications of the TPP for US patients (and patents), and the proper role of public health concerns in international trade negotiations.
Experts:
Thomas Bollyky, JD
Senior Fellow for Global Health, Economics, and Development
Council on Foreign Relations
Amy Kapczynski, JD
Professor of Law
Yale Law School
Moderator:
Jing Luo, MD, MPH
Instructor in Medicine
Harvard Medical School